OC
ALPN

Oppenheimer & Co’s Alpine Immune Sciences Inc ALPN Stock Holding History

Oppenheimer & Co’s Portfolio ALPN Stock Details ALPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-21,538
Closed -$854K – 1539
2024
Q1 		$854K Buy
+21,538
New +$636K 0.01% 795

Oppenheimer & Co's ALPN Position: Q2 2024 in Review

Oppenheimer & Co sold out of Alpine Immune Sciences Inc (ALPN) in Q2 2024, closing a stake of 21,538 shares — an estimated $854K sold.

Oppenheimer & Co first reported a position in ALPN in Q1 2024 and held it in 1 quarter. The position peaked at $854K in Q1 2024. 0 funds tracked by Wall St. Rank hold ALPN as of Q2 2024.

  • Oppenheimer & Co reported no remaining Alpine Immune Sciences Inc position as of Q2 2024 after selling out during the quarter.
  • Oppenheimer & Co sold 21,538 Alpine Immune Sciences Inc shares in Q2 2024, an estimated $854K.
  • Oppenheimer & Co first reported a position in Alpine Immune Sciences Inc in Q1 2024 and held it in 1 quarter.
  • Oppenheimer & Co's Alpine Immune Sciences Inc position peaked at $854K in Q1 2024.
  • 0 funds tracked by Wall St. Rank held Alpine Immune Sciences Inc as of Q2 2024.

Based on Oppenheimer & Co's 13F filing for Q2 2024, filed 8 Aug 2024.